Codes / ICD10CM / A48.52

A48.52 Wound botulism

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Wound botulism

Summary

Wound botulism is a rare but serious form of botulism caused by the neurotoxin produced by Clostridium botulinum bacteria infecting a wound. The toxin disrupts neuromuscular transmission, leading to flaccid paralysis and systemic effects. This condition occurs when the bacteria colonize a wound, typically in anaerobic environments, and produce botulinum toxin locally or systemically.

Causes

Wound botulism is caused by Clostridium botulinum bacteria infecting a wound, often in anaerobic conditions such as deep punctures, surgical sites, or contaminated injuries. The bacteria produce botulinum neurotoxin, which is absorbed into the bloodstream and affects nerve function. Unlike foodborne botulism, the toxin is not preformed in food but is generated by bacterial growth in the wound.

Risk Factors

  • Deep or penetrating wounds (e.g., from trauma, surgery, or injection drug use)
  • Wounds exposed to soil, dust, or animal feces containing C. botulinum spores
  • Injection drug use, particularly with contaminated equipment
  • Poor wound care or delayed treatment of infected injuries
  • Immunocompromised states that reduce resistance to bacterial infections

Symptoms

  • Muscle weakness, starting in the face and descending (e.g., ptosis, diplopia, dysphagia)
  • Dysarthria (slurred speech) or dysphonia (hoarse voice)
  • Dysphagia (difficulty swallowing)
  • Respiratory muscle weakness or shortness of breath
  • Symmetric descending flaccid paralysis
  • Autonomic dysfunction (e.g., dry mouth, constipation, urinary retention)

Diagnosis

Diagnosis of wound botulism involves clinical evaluation of symptoms, history of wound exposure, and laboratory testing. Electromyography (EMG) may show characteristic findings of neuromuscular blockade. Wound cultures or serum testing for botulinum toxin can confirm the presence of the toxin or bacteria. Imaging or wound examination may identify the source of infection.

Treatment Options

Treatment includes prompt administration of botulinum antitoxin to neutralize circulating toxin, wound debridement or surgical cleaning to remove the bacterial source, and supportive care (e.g., mechanical ventilation for respiratory failure). Antibiotics (e.g., penicillin) may be used to eradicate the bacteria, though caution is needed to avoid releasing more toxin. Rehabilitation and physical therapy aid recovery.

Prognosis and Follow-Up

Prognosis depends on early diagnosis and treatment; delays increase the risk of severe complications like respiratory failure. Most patients recover with supportive care, but recovery of nerve function may take weeks to months. Follow-up includes monitoring for residual weakness, respiratory function, and wound healing. Long-term rehabilitation may be necessary for persistent symptoms.

Complications

  • Respiratory failure requiring mechanical ventilation
  • Prolonged muscle weakness or paralysis
  • Secondary infections (e.g., pneumonia)
  • Autonomic dysfunction (e.g., cardiac arrhythmias)
  • Delayed wound healing or sepsis

Lifestyle & Prevention

  • Clean and properly care for wounds, especially deep or contaminated injuries.
  • Avoid injection drug use or use sterile equipment if unavoidable.
  • Seek prompt medical attention for infected or poorly healing wounds.
  • Avoid contact with soil or dust in wounds when possible.
  • Maintain good hygiene to reduce exposure to bacterial spores.

When to Seek Professional Help

Seek immediate medical care if you experience sudden muscle weakness, difficulty swallowing or speaking, or respiratory distress, especially with a recent wound or injection drug use. Early treatment improves outcomes and reduces complications.

Tips for Medical Coders

Document the presence of a wound infection with Clostridium botulinum and confirm botulinum toxin production. Include details of wound location, timing of symptom onset, and laboratory confirmation (e.g., toxin detection, wound culture) to support the diagnosis. Ensure the code A48.52 is used only when wound botulism is clinically confirmed and not confused with other botulism types.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

A48.52 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.